Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2496 |  IMMX Immix Biopharma, Inc. - Common Stock | 13.34 USD | -2.34% | +17.12% | +54.58% | +520.47% | 954.33 M USD | ||
| 2500 |  ARDX Ardelyx, Inc. - Common Stock | 3.80 USD | -2.31% | -6.63% | -25.93% | -38.11% | 946.91 M USD | ||
| 2515 |  CLYM Climb Bio, Inc. - Common Stock | 16.27 USD | -5.84% | -5.41% | +24.20% | +197.44% | 934.49 M USD | ||
| 2525 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.55 USD | -1.31% | -2.76% | -11.94% | +28.82% | 923.10 M USD | ||
| 2533 |  IVA Inventiva S.A. - American Depository Shares | 4.64 USD | -0.85% | -1.28% | +4.50% | -2.73% | 896.62 M USD | ||
| 2544 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.01 USD | 0.00% | +0.29% | +0.83% | +18.54% | 883.14 M USD | ||
| 2582 |  DBVT DBV Technologies S.A. - American Depositary Shares | 14.22 USD | -2.27% | -3.00% | +3.42% | +44.95% | 842.00 M USD | ||
| 2583 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 45.70 USD | -0.41% | +7.55% | +22.52% | +51.68% | 853.67 M USD | ||
| 2614 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 7.87 USD | -1.50% | +6.21% | +27.35% | +149.05% | 809.84 M USD | ||
| 2616 |  AURA Aura Biosciences, Inc. - Common Stock | 7.80 USD | 0.00% | +2.63% | +9.86% | +19.27% | 808.90 M USD | ||
| 2617 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.49 USD | -8.46% | -2.49% | +41.78% | +28.23% | 800.49 M USD | ||
| 2624 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 11.45 USD | -2.72% | -4.58% | -11.58% | -19.71% | 803.42 M USD | ||
| 2633 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 24.20 USD | +2.72% | +26.70% | +24.94% | +251.23% | 788.47 M USD | ||
| 2637 |  STTK Shattuck Labs, Inc. - Common Stock | 7.83 USD | +3.98% | +6.39% | +6.24% | +741.94% | 785.84 M USD | ||
| 2661 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.72 USD | -2.75% | -1.03% | +11.81% | -18.64% | 749.35 M USD | ||
| 2662 |  NGNE Neurogene Inc. - Common Stock | 39.81 USD | +3.05% | +7.92% | +13.74% | +35.32% | 796.65 M USD | ||
| 2687 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.26 USD | +1.98% | +1.98% | +2.89% | +2.21% | 742.41 M USD | ||
| 2688 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.33 USD | +1.52% | -2.92% | +2.46% | +56.34% | 725.60 M USD | ||
| 2691 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.91 USD | +0.45% | -6.11% | -23.19% | -25.44% | 720.83 M USD | ||
| 2699 |  MNPR Monopar Therapeutics Inc. - Common Stock | 109.30 USD | +1.47% | -6.28% | -0.90% | +100.11% | 733.64 M USD |
Noticias Biotechnology Stocks
Las acciones de Alto Neuroscience alcanzan máximos históricos a 35,42 dólares
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
 CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |